Transplacental passage of digoxin in the case of nonimmune hydrops fetalis
Open Access
- 1 January 1987
- journal article
- case report
- Published by Wiley in Clinical Cardiology
- Vol. 10 (1) , 63-65
- https://doi.org/10.1002/clc.4960100115
Abstract
Successful treatment of intrauterine fetal tachyarrhythmia was reported in several cases recently. It was also pointed out that placental transfer of digoxin is unsatisfactory under certain conditions. However, it has not been clearly shown in which cases fetal digoxin level does not reach the maternal level. We present a case of nonimmune hydrops fetalis due to congenital atrial flutter in which digoxin concentration in the sera of the mother and the neonate showed significant dissociation, and discuss perinatological matters about the digoxin treatment and the factor that obstructs the transplacental passage of digoxin. Conclusively, we recommend that maternal digoxin concentration should be raised to near toxic level if the resolution of fetal and placental hydrops is not attained in the initial digoxin loading.Keywords
This publication has 6 references indexed in Scilit:
- Successful Treatment of Fetal Supraventricular Tachycardia with Maternal Digoxin TherapyChest, 1984
- Endogenous substance in newborn infants causingfalse positive digoxin measurementsThe Journal of Pediatrics, 1983
- Successful Treatment of Fetal Congestive Heart Failure Secondary to TachycardiaNew England Journal of Medicine, 1981
- Basic Concepts of Maternal-Fetal Amniotic Fluid Exchange: Their Relevance to Fetal TherapeuticsPediatric Clinics of North America, 1981
- TRANSPLACENTAL CARDIOVERSION OF INTRAUTERINE SUPRAVENTRICULAR TACHYCARDIA WITH DIGITALISThe Lancet, 1980
- Serum Digoxin Concentrations in the Human Fetus, Neonate and InfantNew England Journal of Medicine, 1972